Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tumour Virus Research is Scopus-indexed (Q1, CiteScore 10.5), WoS ESCI, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2666-6790Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 23 / 361 | 93rd | Q1 |
| Virology | 10 / 86 | 88th | Q1 |
| Cancer Research | 45 / 233 | 80th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 10.5.
Tumour Virus Research is Q1 in Infectious Diseases (rank 23 of 361), Q1 in Virology (rank 10 of 86) and Q1 in Cancer Research (rank 45 of 233), by CiteScore 2025.
Tumour Virus Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.5, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.693, quartile Q1, with an H-index of 42.
The publisher lists an article processing charge of about US$3,110 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Tumour Virus Research is published by Elsevier B.V. Its ISSN is 2666-6790.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Tumour Virus Research has an h-index of 18 and a 2-year mean of 3.73 citations per paper (OpenAlex). Its Scopus CiteScore is 10.5, quartile Q1. On 2-year citations it ranks #73 of 354 Scopus journals in Infectious Diseases.
Tumour Virus Research published 22 papers in 2025; its busiest recent year was 2024 with 32. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2021–2026), authors are most often from United States (29.2%), China (12.4%) and United Kingdom (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.